Nationwide Children’s gene therapy spinout raises $2.5M to test muscular dystrophy treatment – Columbus Business First
Columbus Business First |
Nationwide Children's gene therapy spinout raises $2.5M to test muscular dystrophy treatment
Columbus Business First CEO Michael Triplett and COO Bruce Halpryn are based in New Albany, and all of the contract research it sponsors takes place at Children's. “The clinical impact will be transformative. I think it's a matter of when, not if,” Triplett said. “It will … |
